Orthofix Medical Inc. (OFIX)
NASDAQ: OFIX · Real-Time Price · USD
12.57
-0.30 (-2.33%)
Mar 5, 2026, 4:00 PM EST - Market closed
Orthofix Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 822.31 | 799.49 | 746.64 | 460.71 | 464.48 | Upgrade
|
| Revenue Growth (YoY) | 2.85% | 7.08% | 62.06% | -0.81% | 14.25% | Upgrade
|
| Cost of Revenue | 256.3 | 241.42 | 224.32 | 123.54 | 114.91 | Upgrade
|
| Gross Profit | 566.02 | 558.07 | 522.32 | 337.17 | 349.57 | Upgrade
|
| Selling, General & Admin | 554.33 | 532.53 | 530.4 | 308.78 | 290.67 | Upgrade
|
| Research & Development | 65.85 | 73.64 | 80.23 | 49.07 | 49.62 | Upgrade
|
| Amortization of Goodwill & Intangibles | 14.31 | 17.44 | 17.46 | 9.8 | 9.41 | Upgrade
|
| Operating Expenses | 634.49 | 623.6 | 628.08 | 367.64 | 349.7 | Upgrade
|
| Operating Income | -68.47 | -65.53 | -105.77 | -30.47 | -0.13 | Upgrade
|
| Interest Expense | -17.49 | -29.63 | -8.63 | -1.29 | -1.84 | Upgrade
|
| Currency Exchange Gain (Loss) | - | -0.63 | - | -3.29 | -3.98 | Upgrade
|
| Other Non Operating Income (Expenses) | 8.11 | -3.22 | -0.94 | 0.32 | 0.33 | Upgrade
|
| EBT Excluding Unusual Items | -77.85 | -99.01 | -115.34 | -34.72 | -5.62 | Upgrade
|
| Merger & Restructuring Charges | - | -12.19 | -36.04 | - | - | Upgrade
|
| Impairment of Goodwill | - | - | - | - | -11.76 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | -5.78 | - | -0.18 | 0.31 | Upgrade
|
| Asset Writedown | -14.1 | - | - | - | - | Upgrade
|
| Other Unusual Items | 1.14 | -6.9 | 2.7 | 17.2 | 3.58 | Upgrade
|
| Pretax Income | -90.81 | -123.88 | -148.68 | -17.71 | -13.5 | Upgrade
|
| Income Tax Expense | 1.38 | 2.12 | 2.72 | 2.04 | 24.88 | Upgrade
|
| Earnings From Continuing Operations | -92.19 | -126 | -151.4 | -19.75 | -38.38 | Upgrade
|
| Net Income | -92.19 | -126 | -151.4 | -19.75 | -38.38 | Upgrade
|
| Net Income to Common | -92.19 | -126 | -151.4 | -19.75 | -38.38 | Upgrade
|
| Shares Outstanding (Basic) | 40 | 38 | 37 | 20 | 20 | Upgrade
|
| Shares Outstanding (Diluted) | 40 | 38 | 37 | 20 | 20 | Upgrade
|
| Shares Change (YoY) | 3.85% | 3.82% | 83.16% | 1.84% | 1.54% | Upgrade
|
| EPS (Basic) | -2.33 | -3.30 | -4.12 | -0.98 | -1.95 | Upgrade
|
| EPS (Diluted) | -2.33 | -3.30 | -4.12 | -0.98 | -1.95 | Upgrade
|
| Free Cash Flow | -1.28 | -9.09 | -107.8 | -34.7 | 0.69 | Upgrade
|
| Free Cash Flow Per Share | -0.03 | -0.24 | -2.94 | -1.73 | 0.04 | Upgrade
|
| Gross Margin | 68.83% | 69.80% | 69.96% | 73.18% | 75.26% | Upgrade
|
| Operating Margin | -8.33% | -8.20% | -14.17% | -6.61% | -0.03% | Upgrade
|
| Profit Margin | -11.21% | -15.76% | -20.28% | -4.29% | -8.26% | Upgrade
|
| Free Cash Flow Margin | -0.16% | -1.14% | -14.44% | -7.53% | 0.15% | Upgrade
|
| EBITDA | -6.15 | 10.43 | -45.21 | 1.61 | 32.96 | Upgrade
|
| EBITDA Margin | -0.75% | 1.31% | -6.05% | 0.35% | 7.10% | Upgrade
|
| D&A For EBITDA | 62.32 | 75.96 | 60.56 | 32.08 | 33.1 | Upgrade
|
| EBIT | -68.47 | -65.53 | -105.77 | -30.47 | -0.13 | Upgrade
|
| EBIT Margin | -8.33% | -8.20% | -14.16% | -6.61% | -0.03% | Upgrade
|
| Advertising Expenses | - | - | - | - | 0.5 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.